Catalyst Wire Dossier Catalyst Wire Dossier

HLA-A*0201 restricted peptide vaccine

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HLA-A*0201 restricted peptide vaccine, covering 2009-11-19 to 2010-12-24. Get the full timeline:

Most recent: Clinical Trial Update: HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) [Phase 1]

See pricing